TOMI Environmental Solutions, Inc. Reports Strong Q1 2026 Revenue Growth and Strategic Wins

Key Highlights from Preliminary Q1 2026 Financial Results

• Preliminary Q1 2026 revenue of \$1.7 million, up 67% sequentially from Q4 2025
• Integrated projects pipeline grows to \$5.3 million, covering 14 customers, with half already secured
• First quarter sales plus open orders reach approximately \$3.36 million
• BIT Solution sales total \$427,000; iHP Corporate Service sales hit \$729,000
• Secured \$440,000 annual service contract with a leading global medical technology company
• Standalone applicator sales up 139% compared to all of 2025

Detailed Analysis

TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a recognized global leader in disinfection and decontamination solutions, announced preliminary unaudited financial results for the first quarter of 2026 that point to robust operational momentum and a strengthening commercial pipeline.

Strong Revenue Growth Signals Company Momentum

The company reported preliminary revenue of approximately \$1.7 million for Q1 2026, marking a sequential increase of 67% compared to Q4 2025. This surge demonstrates a significant acceleration in business activity across TOMI’s core product and service segments.

Expanding Project Pipeline and Order Book

TOMI’s integrated projects pipeline, which includes projects awaiting capital expenditure approval or those with signed contracts for its SteraMist Integrated System (SIS), Hybrid, or Custom Engineered System (CES) products, has grown to \$5.3 million. Notably, half of these projects are already secured by purchase orders or contracts, indicating a solid foundation for future revenue realization.

Combined first quarter sales and current open orders stand at approximately \$3.36 million, reflecting strong ongoing customer engagement and a healthy backlog.

Performance Across Product and Service Segments

Comparing Q1 2026 to both the prior year’s first quarter and the preceding quarter, TOMI saw broad-based growth in:

• Mobile equipment sales
• Custom integration deliverables
• Repairs and support services

These gains underscore increased customer adoption and utilization of TOMI’s solutions.

Breakdown of Key Sales Categories

• BIT Solution Sales: Approximately \$427,000 in Q1.
• iHP Corporate Service Sales: Approximately \$729,000 in orders delivered or scheduled for delivery this year.

A particularly notable development is a \$440,000 annual purchase order for decontamination services with a leading global medical technology company. This contract provides for quarterly professional decontamination services using TOMI’s SteraMist iHP technology and signifies a transition from emergency response work (which began in 2024) to a stable, recurring revenue relationship. The client is described as a worldwide leader in regenerative medicine, neurosurgery, and reconstructive surgery, highlighting the high standards and mission-critical environments TOMI services.

Surging Demand for Standalone Applicators

The first quarter saw a 139% year-over-year increase in standalone applicator sales utilizing TOMI’s patented cold plasma arc technology. These sales have already surpassed the total for all of 2025, indicating strong market demand and successful expansion of its consumable-based BIT solution model. The company’s strategy to link more applicators to delivery systems tailored to customer preferences appears to be paying off.

What Investors Should Watch

• The 67% sequential revenue growth and the \$5.3 million project pipeline are both highly positive indicators, suggesting an inflection point in the company’s growth trajectory.
• The new \$440,000 recurring service contract with a major healthcare customer signals increased acceptance of TOMI’s solutions in critical life sciences and healthcare environments. This recurring revenue stream could positively impact valuation multiples and support higher share prices if maintained and expanded.
• The surge in standalone applicator sales (up 139%) is material, indicating strong product-market fit and potentially higher future consumables revenue—a key metric for recurring revenue models.
• All results are preliminary and unaudited; final figures may differ once the first quarter closing process is complete and the 10-Q is filed with the SEC.

About TOMI Environmental Solutions, Inc.

TOMI Environmental Solutions, Inc. is a global provider of environmental disinfection solutions, utilizing its proprietary Binary Ionization Technology® (BIT™) platform. Developed in partnership with the Defense Advanced Research Projects Agency (DARPA), the company’s SteraMist® brand uses ionized Hydrogen Peroxide (iHP™) to provide non-caustic, visual, germ-killing aerosol disinfection.

The company’s solutions are used in a wide range of settings, including hospitals, medical facilities, cruise ships, offices, hotels, schools, restaurants, food processing plants, military and emergency services, athletic facilities, and residential buildings. TOMI is a member in good standing with various professional and industry associations, supporting infection control and biosafety.

For more information, visit https://www.steramist.com or contact [email protected].

Forward-Looking Statements and Risks

This article contains forward-looking statements based on current management expectations and trends, including preliminary revenue results, sales pipeline, and recurring revenue prospects. Actual results may differ due to risks such as the ability to close new orders, deliver on contracts, maintain growth, and general economic conditions. Investors are advised to review TOMI’s SEC filings for detailed risk factors.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. All data is based on preliminary, unaudited results and may be subject to change. Investors should conduct their own research and consult with their financial advisor before making investment decisions. TOMI is expected to file its full Q1 2026 results and 10-Q with the SEC in due course.

View TOMI Environmental Solutions, Inc. Historical chart here